BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, Lee JH, Koh KC, Paik SW. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38:1442-1448. [PMID: 29495113 DOI: 10.1111/liv.13732] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Reference Citation Analysis]
2 Hu Y, Wen Z. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy. Sci Rep 2021;11:150. [PMID: 33420233 DOI: 10.1038/s41598-020-80136-0] [Reference Citation Analysis]
3 Lee HA, Kim SU, Seo YS, Lee Y, Kang SH, Jung YK, Kim MY, Kim JH, Kim SG, Suk KT, Jung SW, Jang JY, An H, Yim HJ, Um SH. Prediction of the varices needing treatment with non‐invasive tests in patients with compensated advanced chronic liver disease. Liver Int 2019;39:1071-9. [DOI: 10.1111/liv.14036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
4 Thabut D, Weil D, Bouzbib C, Rudler M, Cassinotto C, Castéra L, Serste T, Oberti F, Ganne-Carrié N, de Lédinghen V, Bourlière M, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PORTAL HYPERTENSION. Clin Res Hepatol Gastroenterol 2021;:101767. [PMID: 34332128 DOI: 10.1016/j.clinre.2021.101767] [Reference Citation Analysis]
5 Kang SH, Baik SK, Kim MY. Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease. J Korean Med Sci 2020;35:e249. [PMID: 32743990 DOI: 10.3346/jkms.2020.35.e249] [Reference Citation Analysis]
6 Samanta T, Biswas K, Ghosh S, Gupta MK, Basu R, Purkait R, Naskar A, Butta S, Das D, Ganguly S. Validation of Revised Baveno VI Criteria for Screening of Varices Needing Treatment in Children with Cirrhosis. Clin Exp Gastroenterol 2020;13:503-9. [PMID: 33177858 DOI: 10.2147/CEG.S276182] [Reference Citation Analysis]
7 Li Q, Wang R, Guo X, Li H, Shao X, Zheng K, Qi X, Li Y, Qi X. Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy. Gastroenterology Research and Practice 2019;2019:1-15. [DOI: 10.1155/2019/6704673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
8 Gaete MI, Díaz LA, Arenas A, González K, Cattaneo M, Fuster F, Henríquez R, Soza A, Arrese M, Barrera F, Arab JP, Benítez C. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. Liver Int 2020;40:1427-34. [PMID: 31916360 DOI: 10.1111/liv.14373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Dajti E, Alemanni LV, Marasco G, Montagnani M, Azzaroli F. Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? Hepat Med 2021;13:25-36. [PMID: 33776492 DOI: 10.2147/HMER.S278077] [Reference Citation Analysis]
10 Protopapas AA, Mylopoulou T, Papadopoulos VP, Vogiatzi K, Goulis I, Mimidis K. Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study. Ann Gastroenterol. 2020;33:87-94. [PMID: 31892803 DOI: 10.20524/aog.2019.0429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Stefanescu H, Marasco G, Calès P, Fraquelli M, Rosselli M, Ganne‐carriè N, Ledinghen V, Ravaioli F, Colecchia A, Rusu C, Andreone P, Mazzella G, Festi D. A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices. Liver Int 2019;40:175-85. [DOI: 10.1111/liv.14228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Bangaru S, Benhammou JN, Tabibian JH. Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis. World J Hepatol 2020; 12(11): 908-918 [PMID: 33312418 DOI: 10.4254/wjh.v12.i11.908] [Reference Citation Analysis]
13 Shearer J, Chizhande D, Jones R, Rowe IA. Non-invasive prediction of oesophageal varices in patients with cirrhosis secondary to non-alcoholic fatty liver disease. Journal of Hepatology 2018;69:1202-3. [DOI: 10.1016/j.jhep.2018.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol 2021;45:101598. [PMID: 33780835 DOI: 10.1016/j.clinre.2020.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Szakács Z, Erőss B, Soós A, Mátrai P, Szabó I, Pétervári E, Bajor J, Farkas N, Hegyi P, Illés A, Solymár M, Balaskó M, Sarlós P, Szűcs Á, Czimmer J, Vincze Á, Pár G. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis. Front Physiol 2019;10:1028. [PMID: 31481896 DOI: 10.3389/fphys.2019.01028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Wu S, Shi Y, Chen S, Kong Y, Ma H, Ou X, Jia J, You H. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM. Liver Int 2021;41:369-77. [PMID: 33277803 DOI: 10.1111/liv.14752] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Reference Citation Analysis]
18 Nawalerspanya S, Sripongpun P, Chamroonkul N, Kongkamol C, Piratvisuth T. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies. Ann Hepatol 2020;19:209-13. [PMID: 31607647 DOI: 10.1016/j.aohep.2019.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
19 de Franchis R. The Changing Scenario of Screening and Surveillance of Esophageal Varices. Gastroenterology 2019;156:864-6. [DOI: 10.1053/j.gastro.2019.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Asesio N, Pollo-Flores P, Caliez O, Munteanu M, Ngo A, Ngo Y, Poynard T, Thabut D, Rudler M. Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis. Dig Liver Dis 2021:S1590-8658(21)00773-8. [PMID: 34583904 DOI: 10.1016/j.dld.2021.09.004] [Reference Citation Analysis]
21 Martínez-Campreciós J, Pons M, Genescà J. Beyond Baveno VI: How far are we? Dig Liver Dis 2019;51:1141-3. [PMID: 31345765 DOI: 10.1016/j.dld.2019.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
22 Zhao W, Xue N, Cui P, Liu L, Wang Y, Zhang X, Tang Y, Du H, Nan Y. Plasma YAP1 predicts esophageal varices and the risk of variceal bleeding in liver cirrhosis. Biomark Med 2021;15:1411-22. [PMID: 34533050 DOI: 10.2217/bmm-2020-0573] [Reference Citation Analysis]
23 Kang Y, Park S, Kim S, Han SJ, Koh H. Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix. Clin Res Hepatol Gastroenterol 2021;45:101437. [PMID: 32417223 DOI: 10.1016/j.clinre.2020.04.007] [Reference Citation Analysis]
24 Li Q, Wu Y, Zhu Q, Meng F, Lin S, Liu B, Li B, Tang S, Yang Y, Li Y, Yuan S, Chen Y, Qi X. External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study. Ann Transl Med 2019;7:755. [PMID: 32042771 DOI: 10.21037/atm.2019.11.78] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
25 Hydes T, Moore M, Stuart B, Kim M, Su F, Newell C, Cable D, Hales A, Sheron N. Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data. BMJ Open 2021;11:e044952. [PMID: 33574154 DOI: 10.1136/bmjopen-2020-044952] [Reference Citation Analysis]
26 Calès P, Buisson F, Ravaioli F, Berger A, Carboni C, Marasco G, Festi D. How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests. Liver Int 2019;39:49-53. [PMID: 30129700 DOI: 10.1111/liv.13945] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
27 Agarwal A, Pathak P, Gupta S, Kumar R, Shalimar. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment. Indian J Gastroenterol 2021. [PMID: 33991311 DOI: 10.1007/s12664-020-01141-9] [Reference Citation Analysis]
28 Dajti E, Ravaioli F, Colecchia A, Marasco G, Calès P, Festi D. “Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?”. Digestive and Liver Disease 2019;51:456-7. [DOI: 10.1016/j.dld.2018.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Agarwal S, Sharma S, Kumar M, Venishetty S, Bhardwaj A, Kaushal K, Gopi S, Mohta S, Gunjan D, Saraya A, Sarin SK. Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept. J Gastroenterol Hepatol 2021. [PMID: 34050561 DOI: 10.1111/jgh.15560] [Reference Citation Analysis]
30 . UEG Week 2018 Oral Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Lejealle C, Castera L. Non-invasive Fibrosis Testing in Patients with Chronic Hepatitis B. Curr Hepatology Rep 2018;17:492-501. [DOI: 10.1007/s11901-018-0439-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Elmahdy AM, Berzigotti A. Non-invasive Measurement of Portal Pressure. Curr Hepatology Rep 2019;18:20-7. [DOI: 10.1007/s11901-019-00446-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Saraya A. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort. Am J Gastroenterol 2020;115:1650-6. [PMID: 32516202 DOI: 10.14309/ajg.0000000000000722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Garcovich M, Di Stasio E, Zocco MA, Riccardi L, Ainora ME, Annicchiarico BE, Gibiino G, Santopaolo F, Gasbarrini A, Pompili M. Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study). Liver Int 2020;40:1952-60. [PMID: 32510772 DOI: 10.1111/liv.14558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Stafylidou M, Paschos P, Katsoula A, Malandris K, Ioakim K, Bekiari E, Haidich AB, Akriviadis E, Tsapas A. Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1744-1755.e11. [PMID: 31077823 DOI: 10.1016/j.cgh.2019.04.062] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 12.3] [Reference Citation Analysis]
36 El-Kassas M, Elakel W, Alboraie M, Ezzat R, Abdelhakam S, Hassany M, Ali-Eldin Z, Sherief AF, Yosry A, El-Serafy M, El-Sayed MH, Waked I, Doss W, Esmat G; Egyptian National Committee for Control of Viral Hepatitis. Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study. Arab J Gastroenterol 2022:S1687-1979(22)00030-2. [PMID: 35473688 DOI: 10.1016/j.ajg.2022.04.003] [Reference Citation Analysis]
37 Ferreira-Silva J, Gaspar R, Liberal R, Cardoso H, Macedo G. Transient splenic elastography predicts high-risk esophageal varices in patients with non-cirrhotic portal hypertension. Scand J Gastroenterol 2021;56:1462-6. [PMID: 34428123 DOI: 10.1080/00365521.2021.1968485] [Reference Citation Analysis]
38 Cunningham ME, Parastandeh-Chehr G, Cerocchi O, Wong DK, Patel K. Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension. Can J Gastroenterol Hepatol 2019;2019:1808797. [PMID: 30881946 DOI: 10.1155/2019/1808797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
39 Giannini EG, De Maria C, Crespi M, Demarzo MG, Fazio V, Grasso A, Torre F, Bodini G, Marabotto E, Furnari M. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease. Eur J Clin Invest 2020;50:e13231. [PMID: 32291753 DOI: 10.1111/eci.13231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Corma-Gómez A, Macías J, Morano L, Rivero A, Téllez F, Ríos MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera-Méndez FJ, Galindo MJ, Pineda JA; RIS-HEP13 and GEHEP 011 Study Groups. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response. Clin Infect Dis 2021;72:e96-e102. [PMID: 33211801 DOI: 10.1093/cid/ciaa1726] [Reference Citation Analysis]
41 Tosetti G, Primignani M, La Mura V, D'Ambrosio R, Degasperi E, Mezzina N, Viganò M, Rumi M, Fracanzani AL, Lombardi R, Fargion S, Fraquelli M, Aghemo A, Lampertico P. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease. Dig Liver Dis 2019;51:1135-40. [PMID: 30691777 DOI: 10.1016/j.dld.2018.12.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]